Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

Medicine and Dentistry

• Anticoagulant Therapy 100%
• Patient 90%
• Cancer Diagnosis 30%
• Atrial Fibrillation 30%
• Major Adverse Cardiac Event 30%
• Major Bleeding 30%
• Malignant Neoplasm 20%
• Oral Submucous Fibrosis 20%
• Cancer 20%
• Diagnosis 10%
• Combination Therapy 10%
• Adverse Event 10%
• Follow up 10%
• Anticoagulation 10%
• Propensity Score Matching 10%
• Cancer Therapy 10%
• Thromboembolism 10%
• Survival 10%
• Inpatient 10%
• Patient with Cancer 10%